These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26122463)

  • 21. Site- and species-specific hydrolysis rates of heroin.
    Szöcs L; Orgován G; Tóth G; Kraszni M; Gergó L; Hosztafi S; Noszál B
    Eur J Pharm Sci; 2016 Jun; 89():105-14. PubMed ID: 27130543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical comparison of shake-flask, potentiometric and chromatographic methods for lipophilicity evaluation (log P
    Port A; Bordas M; Enrech R; Pascual R; Rosés M; Ràfols C; Subirats X; Bosch E
    Eur J Pharm Sci; 2018 Sep; 122():331-340. PubMed ID: 30006180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thyroid hormones and their precursors. II. Species-specific properties].
    Tóth G; Noszál B
    Acta Pharm Hung; 2014; 84(1):21-37. PubMed ID: 24809164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theoretic significance of pH dependence of narcotics and narcotic antagonists in clinical anesthesia.
    Benson DW; Kaufman JJ; Koski WS
    Anesth Analg; 1976; 55(2):253-6. PubMed ID: 3994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Synthesis and investigation of protonation properties and lipophilicity of some new quinazolone-3-carboxylic acid derivatives].
    Almási J; Kökösi J; Takácsné NK; Vámos J; Noszál B
    Acta Pharm Hung; 1999 Sep; 69(4):193-201. PubMed ID: 10544519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orientation of the oxygen atom at C-6 as a determinant of agonistic activity in the oxymorphone series.
    Ronai AZ; Foldes FF; Hahn EF; Fishman J
    J Pharmacol Exp Ther; 1977 Mar; 200(3):496-500. PubMed ID: 66306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands.
    Fang X; Larson DL; Portoghese PS
    J Med Chem; 1997 Sep; 40(19):3064-70. PubMed ID: 9301669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxilorphan (l-N-cyclopropylmethyl-3,14-dihydroxymorphinan): a new synthetic narcotic antagonist.
    Pircio AW; Gylys JA
    J Pharmacol Exp Ther; 1975 Apr; 193(1):23-34. PubMed ID: 237112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in microspeciation of drugs and biomolecules: Species-specific concentrations, acid-base properties and related parameters.
    Mazák K; Noszál B
    J Pharm Biomed Anal; 2016 Oct; 130():390-403. PubMed ID: 27066736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of 3-O-Carboxyalkyl Morphine Derivatives and Characterization of Their Acid-Base Properties.
    Köteles I; Mazák K; Tóth G; Horváth P; Kiss E; Tűz B; Hosztafi S
    Chem Biodivers; 2021 Jul; 18(7):e2100135. PubMed ID: 34018677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Historical perspective on the chemistry and development of naltrexone.
    Archer S
    NIDA Res Monogr; 1981; 28():3-10. PubMed ID: 6791011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
    Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipophilicity of amphoteric and zwitterionic compounds: A comparative study of determination methods.
    Ràfols C; Subirats X; Rubio J; Rosés M; Bosch E
    Talanta; 2017 Jan; 162():293-299. PubMed ID: 27837832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of lipophilicity of two quinolone antibacterials, ciprofloxacin and grepafloxacin, in the protonation equilibrium.
    Sun J; Sakai S; Tauchi Y; Deguchi Y; Chen J; Zhang R; Morimoto K
    Eur J Pharm Biopharm; 2002 Jul; 54(1):51-8. PubMed ID: 12084502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biorelevant physicochemical profiling of (E)- and (Z)-resveratrol determined from isomeric mixtures.
    Orgován G; Gonda I; Noszál B
    J Pharm Biomed Anal; 2017 May; 138():322-329. PubMed ID: 28242573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between immobilized artificial membrane (IAM) HPLC data and lipophilicity in n-octanol for quinolone antibacterial agents.
    Barbato F; Cirocco V; Grumetto L; Immacolata La Rotonda M
    Eur J Pharm Sci; 2007 Aug; 31(5):288-97. PubMed ID: 17540545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of oxymorphone as decomposition product of the permitted drug methylnaltrexone.
    Sobolevsky T; Kucherova Y; Ahrens B
    Drug Test Anal; 2018 May; 10(5):892-895. PubMed ID: 29314653
    [No Abstract]   [Full Text] [Related]  

  • 38. Site-specific protonation microequilibria of penicillin and cephalosporin beta-lactam core molecules.
    Kóczián K; Szakács Z; Kökösi J; Noszál B
    Eur J Pharm Sci; 2007 Sep; 32(1):1-7. PubMed ID: 17588727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicochemical Profiling of α-Lipoic Acid and Related Compounds.
    Mirzahosseini A; Szilvay A; Noszál B
    Chem Biodivers; 2016 Jul; 13(7):861-9. PubMed ID: 27272749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extension of the liquid chromatography/quantitative structure-property relationship method to assess the lipophilicity of neutral, acidic, basic and amphotheric drugs.
    Pallicer JM; Calvet C; Port A; Rosés M; Ràfols C; Bosch E
    J Chromatogr A; 2012 Jun; 1240():113-22. PubMed ID: 22537604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.